Pablo Castro-Cordova
Overview
Explore the profile of Pablo Castro-Cordova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castro-Cordova P, Lopez-Garcia O, Orozco J, Montes-Bravo N, Gil F, Pizarro-Guajardo M, et al.
bioRxiv
. 2025 Feb;
PMID: 39974910
The most common cause of healthcare-associated diarrhea and colitis in the U.S., is , a spore-forming pathogen. Two toxins, TcdA and TcdB, are major virulence factors essential for disease manifestations,...
2.
Court A, Parra-Crisostomo E, Castro-Cordova P, Abdo L, Aragao E, Lorca R, et al.
J Transl Med
. 2024 Sep;
22(1):868.
PMID: 39334383
Background: Apoptosis, a form of programmed cell death, is critical for the development and homeostasis of the immune system. Chimeric antigen receptor T (CAR-T) cell therapy, approved for hematologic cancers,...
3.
Castro-Cordova P, Pizarro-Guajardo M, Romero-Rodriguez A
Front Cell Infect Microbiol
. 2023 Mar;
13:1176453.
PMID: 36968118
No abstract available.
4.
Castro-Cordova P, Otto-Medina M, Montes-Bravo N, Brito-Silva C, Lacy D, Paredes-Sabja D
Infect Immun
. 2022 Nov;
91(1):e0047622.
PMID: 36448839
Clostridioides difficile causes antibiotic-associated diseases in humans, ranging from mild diarrhea to severe pseudomembranous colitis and death. A major clinical challenge is the prevention of disease recurrence, which affects nearly...
5.
Castro-Cordova P, Mora-Uribe P, Reyes-Ramirez R, Cofre-Araneda G, Orozco-Aguilar J, Brito-Silva C, et al.
Nat Commun
. 2022 Apr;
13(1):2465.
PMID: 35487940
No abstract available.
6.
Castro-Cordova P, Mendoza-Leon M, Paredes-Sabja D
PLoS One
. 2021 Dec;
16(12):e0261081.
PMID: 34936648
Interaction of Clostridioides difficile spores with the intestinal mucosa contributes to the persistence and recurrence of the infection. Advanced age is one of the main risk factors for C. difficile...
7.
Castro-Cordova P, Mora-Uribe P, Reyes-Ramirez R, Cofre-Araneda G, Orozco-Aguilar J, Brito-Silva C, et al.
Nat Commun
. 2021 Feb;
12(1):1140.
PMID: 33602902
Clostridioides difficile spores produced during infection are important for the recurrence of the disease. Here, we show that C. difficile spores gain entry into the intestinal mucosa via pathways dependent...
8.
Maia A, Reyes-Ramirez R, Pizarro-Guajardo M, Saggese A, Castro-Cordova P, Isticato R, et al.
Int J Mol Sci
. 2020 Feb;
21(4).
PMID: 32074955
, formerly known as , is a spore-forming bacterium considered as the most common cause of nosocomial infections in developed countries. The spore of is involved in the transmission of...
9.
Castro-Cordova P, Diaz-Yanez F, Munoz-Miralles J, Gil F, Paredes-Sabja D
Anaerobe
. 2020 Jan;
62:102149.
PMID: 31940467
The anaerobic bacterium Clostridioides difficile is the leading cause of antibiotic-associated diarrhea that can culminate in life-threating colitis. During the C. difficile infection (CDI), C. difficile produces toxins that generate...
10.
Munoz-Miralles J, Trindade B, Castro-Cordova P, Bergin I, Kirk L, Gil F, et al.
Future Microbiol
. 2018 Sep;
13:1271-1281.
PMID: 30238771
Aim: To evaluate the effect on the nonsteroidal anti-inflammatory drug indomethacin on Clostridium difficile infection (CDI) severity. Materials & Methods: Indomethacin was administered in two different mouse models of antibiotic-associated...